热门资讯> 正文
Vyome收购Oculo，这是一家在麻省理工学院成立的人工智能初创公司，并推出了一个专注于使用人工智能应对炎症的新业务部门;交易条款未披露
2025-09-29 19:07
- This new business unit will leverage Oculo's assets to develop an AI psychiatrist trained on data from both the US and India, and will be overseen by a newly-formed Vyome Board of Directors AI subcommittee comprised of Krishna Gupta, Mohanjit Jolly, and Stash Pomichter – all of whom are MIT alumni with deep AI expertise.
- The Oculo transaction will have no bearing on the progress of Vyome's core biotech assets. Vyome remains funded through 2026 to progress its core business.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
